Conference Calendar
Alzheimer's Association International Conference 2016
– DOWNLOAD TO YOUR CALENDAR
Toronto, Canada
View Conference Website
Join international investigators, clinicians and care providers as they gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.
Past AlzForum Coverage:
- Alzheimer's Association International Conference 2013
- Cerebrospinal Fluid Tau Climbs in Aβ Mouse Models
- Coverage Denial For Amyloid Scans Riles Alzheimer’s Community
- Pooled GWAS Reveals New Alzheimer’s Genes and Pathways
- Are Subtle Memory Concerns a Sign of Future Dementia?
- Clinical Trials Roundup: Four Hits, No Home Runs
- Clinical Trials Roundup: Broadening the Lines of Attack
- Curbing Innate Immunity Boosts Synapses, Cognition
- Scientists Hunting Rare Alzheimer’s Mutations Eye Phospholipase D3
- Biomarkers Predict Alzheimer’s, But Shoe Does Not Always Fit
- Suspected Non-Amyloid Pathology (SNAP)—Not an Open or Shut Case
- Dementia Prevalence Falls in England
- Are Protein Strains The Cause of Different Tauopathies?
- Tau Tracers Shine at Boston Conference
- Tales of Traveling Tau: Is Transfer Between Neurons Normal?
- Alzheimer's Association International Conference 2012
- Experimental α7 Agonist Meets Cognitive and Clinical Endpoints
- New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity
- Q&A With Roche’s CNS Leader Luca Santarelli
- When Is a C9ORF72 Repeat Expansion Not a C9ORF72 Repeat Expansion?
- Wave of New BACE Inhibitors Heading to Phase 2
- Researchers Join to Draw Posterior Cortical Atrophy Out of Shadows
- Cochrane Asks for Field’s Input on Draft Reporting Standards
- Can We All Agree on How to Draw a Hippo(campus)?
- Collaborative Umbrella CAPs Three Prevention Trial Initiatives
- On Risk, Benefit, and More, Prevention Initiatives Take Questions
- In Big Picture, Familial AD’s Biomarker Data Resemble LOAD
- Dimmed Network Connections May Explain Metabolic Shortfall
- To Reveal or Not to Reveal? New Data on the Question
- iPSC Disease Models Up and Coming for AD, Down’s, ALS
- GWAS Mega-Meta Yields More Risk Genes, BIN1 Binds Tau?
- Night Owl? Early Bird? Good Night’s Sleep May Protect the Brain
- Plaque May Quash Seesawing CSF Aβ Levels
- Could Sortilin Be a Sweet Spot for FTD Therapy?
- Alzheimer's Association International Conference on Alzheimer's Disease 2011
- Paris: Renamed ARIA, Vasogenic Edema Common to Anti-Amyloid Therapy
- Paris: Semagacestat Autopsy and Other News of Trial Tribulations
- Paris: More Trial News, Mixed at Best
- Paris: President and All, French Science Takes the Stage
- Paris: Beyond Genomics, French Science Draws on Populations, Patients
- Paris: Studies Strengthen Link Between Brain Injury and Dementia
- Paris: Standardization a Hurdle for Spinal Fluid, Imaging Markers
- Alzheimer's Association International Conference on Alzheimer's Disease 2010
- Honolulu: FDA Approval in Sight for 18F Amyloid Tracer Florbetapir?
- Honolulu: Tomm40 Reported to Track With Brain Atrophy, Cognition
- Honolulu: TrialMatch Launched as AD Is Becoming “Desktop” Disease
- Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at Synapse
- Honolulu: Wake-Up Call—Aβ Clearance, Not Production, Awry in AD
- Honolulu: Intranasal Insulin Trial Claims Promise in MCI, AD
- Honolulu: TDP-43 Gets a Place in the Sun
- Honolulu: Neuroregeneration Taps Glia, Neurotrophins
- Noisy Response Greets Revised Diagnostic Criteria for AD
- Revised Criteria for Preclinical AD, Exactly as Presented
- What Do Clinicians Say? Peers Welcome Revised Criteria
- Honolulu: Monkey, Rat Join Menagerie of Mammalian AD Models
- Honolulu: Biomarker Profiles That Spell Trouble for ‘Normals’?
- International Conference on Alzheimer's Disease 2009
- Vienna: New Genes, Anyone? ICAD Saves Best for Last
- Vienna: In Genetics, Bigger Is Better—Data Sharing Nets Three New Hits
- Vienna: Can a D-Peptide Turn Tiger Into Pussycat?
- Vienna: New Shoot Among Ashes of Drug Trials
- Vienna: New Tack to See Amyloid Oligomers in Body Fluids
- Vienna (and Burkina Faso): What's New With Methylene Blue?
- International Conference on Alzheimer's Disease 2008
- Chicago: Studies Probe Diminishing Placebo Decline, Part 1
- Chicago: Studies Probe Diminishing Placebo Decline, Part 2
- Chicago: ICAD Offered Mix Bag of Setbacks and Hopeful News
- Chicago: Trial Design Bedevils Search for New AD Drugs, Part 1
- Chicago: The Phase 2 Problem and the Way to a Surrogate, Part 2
- Chicago: Out of the Blue—A Tau-based Treatment for AD?
- Chicago: Dimebon Safe for 18 Months
- Chicago: Bapineuzumab’s Phase 2—Was the Data Better Than the Spin?
- Chicago: Lilly’s Antibody Appears to Do No Harm, But Will It Help?
- Chicago: APP Roles in Caspase Gene Regulation, Muscle Function?
- Chicago: Flurizan Postmortem
- Chicago: Translational and Basic Science of Tau Advances
- Chicago: Brain-Penetrant Microtubule Stabilizer in Tauopathy Mice
- Chicago: Tau Projection Domain May Block Excitotoxicity in Mice
- Chicago: Does Saying “I Do” Lower Late-life Dementia Risk?
- Chicago: More News From Phase 2s
- Chicago: More Phase 2 News—PBT2 and IVIg
- Chicago: Phase 2 News—Therapeutic Breakfast Food?
- Alzheimer's Association International Conference 2007
- Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments
- Washington: Shaking Up AD Treatment with Ketone Bodies
- Washington: Site-to-Site Differences Delay Result of Alzhemed Trial
- Washington: γ-secretase Inhibitor Survived Phase 2, Moving to 3
- Washington: Functional Improvement From Stopped Vaccine
- International Conference on Alzheimer's Disease 2004
- Philadelphia: All Eyes on PIB Imaging—Is It Coming Along?
- Philadelphia: All Is Not Well with the Statin Story
- Philadelphia: Can a Shrinking Brain Be Good for You?
- Philadelphia: Dementia Types Just Won’t Fit into Little Boxes
- Philadelphia: Diagnosis Light—Toward Infrared Plaques
- Philadelphia: European Trial of Alzhemed Ends, Marketing Morphs to Supplement
- Philadelphia: Mom Was Right. Eat Your Carrots!
- Philadelphia: Targets in a Barely Tapped Market Keep Big Pharma Focused on AD
- Philadelphia: The Enemy Within—Neurodegeneration From Intraneuronal Aβ
- International Conference on Alzheimer's Disease 2002
- Stockholm: Visualizing Amyloid Biggest Draw at Imaging Symposium, Consensus Sought on Validation
- Stockholm: Chlamydia Triggers Amyloid Plaques in Mice
- Stockholm: Aph-1 and Pen-2: New Names in the Presenilin Debate Complete the Complex?
- Stockholm: Clusterin (or Beware the Evil Chaperone!)
- Stockholm: Gold in Them Thar Hills?
- Stockholm: Not All NSAIDs Are Equally Good When it Comes to Alzheimer’s
- Stockholm: Separating Good from Bad Inflammation in AD: Complement Steps into Limelight
- Stockholm: Larger Study Finds Protective Effect of Statin Use
- Stockholm: Liver Found to Degrade Aβ
- Stockholm: Bad News Official: The Rofecoxib and Naproxen Clinical Trial Has Failed
- Stockholm: Presenting α-T Catenin: A Long-Awaited Gene on Chromosome 10?
- Stockholm: Educated Guessing Game: Which Genes Does “Other” APP Snippet Regulate?
- Stockholm: Could a Whiff of NAP Nip Brain Inflammation in the Bud?
- Stockholm: There Is No Spatial Paradox!
- Stockholm: The Presenilin Signaling Hub—A RIP-off or the Real Deal?
- Stockholm: Degradation on the Rise
- Stockholm: Core Resistance
- Stockholm: Pictures at an Exhibition
- International Conference on Alzheimer's Disease 1998
- Sixth Int. Conference on AD: Mechanisms of Neurodegenerative Conditions I
- Sixth Int. Conference on AD: Genetics I
- Sixth Int. Conference on AD: Monkey Brain Injections
- Sixth Int. Conference on AD: Cellular/Animal Models I
- Sixth Int. Conference on AD: Mechanisms of Neurodegenerative Conditions II
- Sixth Int. Conference on AD: Towards the Next Generation of AD Therapeutics
- Sixth Int. Conference on AD: Mahley Plenary Lecture
- Sixth Int. Conference on AD: Mechanisms of Neurodegerative Conditions III
- Sixth Int. Conference on AD: Pathology I
- Sixth Int. Conference on AD: Molecular Interactions in AD Pathogenesis
- Sixth Int. Conference on AD: Development of Aβ Peptide Inhibitors
- Sixth Int. Conference on AD: Roundtable C: Metabolism and Alzheimer's
- Sixth Int. Conference on AD: Satellite Symposium on AD7c-NTP
- Sixth Int. Conference on AD: Aging Astrocytes: A Role in AD?
- Sixth Int. Conference on AD: Fibril-busting Mystery Herb
- Sixth Int. Conference on AD: Presenilin-binding Proteins Abound
- Sixth Int. Conference on AD: Search for Late-Onset AD Genes
- Sixth Int. Conference on AD: Scientists Smitten by Mad Tau Disease